Calidutherm ÖKO

Hazard statements (CLP)

H315, H318, H335, H373

Code

Statements

H315

Causes skin irritation

CLP CLASSIFICATION

Skin irritation 2, H315 Serious eye damage 1, H318 STOT SE 3, H335 STOT RE 2, H373 2.1.2 According to directive 1999/45/EG Irritant Xi, R37/38, R41

Further information

The full wording of the R phrases, hazard statements and EU hazard statements can be found in section 16. This product contains respirable quartz as an impurity and is therefore classified as STOT RE2 under the criteria defined in Regulation (EC) No 1272/2008 and, because of the potential for the formation of airborne respirable crystalline silica, as a dangerous preparation pursuant to Directive 67/548/EEC. Depending on how the product is handled and used (e.g. grinding, drying), it may lead to the formation of airborne respirable crystalline silica (quartz/cristobalite). Prolonged and / or intensive inhalation of respirable crystalline silica can lead to silicosis. The main symptoms of silicosis are coughing and respiratory problems / shortness of breath. In the event of sporadic exposure to respirable crystalline silica, suitable protective and monitoring measures should be available. Special care must be taken during handling of the product to avoid dust formation. If the binding agent comes into contact with water or becomes moist, it forms a strongly alkaline solution. As a result of the high alkalinity, moist binding agents can cause inflammation of the skin and eyes. Regulation (EC) No. 1272/2008: Caution: STOT RE2 H373: May cause damage to the lungs through prolonged or repeated exposure by inhalation.

2.2 Label elements

2.2.1 Labelling in accordance with regulation (EC) Nr. 1272/2008

Hazard statements

H315 Cause skin irritation. H318 causes serious eye damage. H335 May cause respiratory irriation. H373 May cause damage to the lungs through prolonged or repeated exposure by Inhalation. Safety instructions P260 Do not breathe dust. P280 Wear protective gloves/protective clothing/eye protection. P285 In case of inadequate ventilation wear respiratory protection. P314 Get medical advice/attention if you feel unwell. P305+P351+P338+P310 IF IN EYE: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor/physician. P302+P352+P333+P313 IF ON SKIN: Wash with plenty of soap and water. If skin irritation or rash occurs: Get medical advice/attention. P261+P304+P340+P312 Avoid breathing dust. IF INHALE: Remove victim to fresh air and keep at rest in a position comfortable for breathing. Call a POISON CENTER or doctor/physician if you feel unwell. If the product is sold to the general public, the following statements also apply: P102 Keep out of reach of children. P501 Dispose of contents/container to suitable waste collection points.

Supplemental label elements

The number of months for which the product remains low in chromate after the manufacturing date, if stored properly in a dry place, is stated on the delivery note or on the paper bags.

2.3 Other hazards

The binding agent does not meet the criteria for PBT or vPvB in accordance with Annex XIII of the REACH Regulation (EC) No 1907/2006. The product contains chromate reducing agents, leading to a water-soluble chromium (VI) content of less than 0.0002%. In the event of incorrect storage (ingress of moisture) or storage for too long, the contained chromate reducing agents may prematurely lose their effectiveness, and the binding agent may have a sensitizing effect on contact with skin (R43/H317 or EUH203).